Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza ® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART)

Condition:   HIV-1-infection Intervention:   Drug: Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (FDC) Sponsors:   The Crofoot Research Center, Inc.;   Janssen Scientific Affairs, LLC Not yet recruiting

Source: ClinicalTrials.gov - May 14, 2020 Category: Research Source Type: clinical trials